| Literature DB >> 23725060 |
Ling-Yan Jiang1, Shang-Guang Chen, Yuan-Yuan Zhang, Jian-Zhong Liu.
Abstract
BACKGROUND: L-ornithine is effective in the treatment of liver diseases and helps strengthen the heart. The commercial applications mean that efficient biotechnological production of L-ornithine has become increasingly necessary. Adaptive evolution strategies have been proven a feasible and efficient technique to achieve improved cellular properties without requiring metabolic or regulatory details of the strain. The evolved strains can be further optimised by metabolic engineering. Thus, metabolic evolution strategy was used for engineering Corynebacterium glutamicum to enhance L-ornithine production.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23725060 PMCID: PMC3681597 DOI: 10.1186/1472-6750-13-47
Source DB: PubMed Journal: BMC Biotechnol ISSN: 1472-6750 Impact factor: 2.563
L-Ornithine production by different strains
| 20.1 ± 0.7 | 10.2 ± 0.2 | 1.8 ± 0.1 | |
| 18.5 ± 0.3* | 11.3 ± 0.3* | 2.2 ± 0.2* | |
| 23.5 ± 1.4* | 13.6 ± 0.5* | 2.1 ± 0.1 | |
| 28.0 ± 1.2# | 12.2 ± 0.3# | 1.6 ± 0.1# | |
| 24.5 ± 1.0# | 14.3 ± 0.5# | 2.1 ± 0.2# | |
| 22.6 ± 1.9# | 13.1 ± 0.2# | 2.1 ± 0.2# | |
| 22.7 ± 0.1* | 17.3 ± 0.4* | 2.7 ± 0.2* |
*Significantly different from the parent strain. #Significantly different from ΔAPE6937(pEC-XK99E).
Figure 1Growth of . () during adaptive evolution.
Figure 2Levels of select transcripts in the evolved strains . ΔAPE6937 (A) and . ΔAPE6937R42 (B) compared with those of the parent strain . ΔAPE at 54 h in shake flasks. Abundances of each transcript in ΔAPE6937 or ΔAPE6937R42, determined using qRT-PCR, were normalised relative to levels of the same transcript in the parental strain.
Concentrations of NADPH in the different strains
| 22.4 ± 1.0 | 34.2 ± 0.2 | 17.0 ±0.6 | |
| 13.7 ± 0.3 | 11.6 ± 0.2 | 12.4 ± 0.6 |
Figure 3Levels of transcripts involved in NADPH biosynthesis in . ΔAPE6937R42 compared with those in . ΔAPER grown at 54 h in shake flasks. Abundances of transcripts in ΔAPE6937R42, determined using qRT-PCR, were normalised relative to levels of the same transcript in ΔAPER.
Effect of over-expression of gene in . ΔAPER on L-ornithine production
| pEC-XK99E | 14.6 ± 0.1* | 1.2 ± 0.15* | 14.2 ± 0.4* |
| pEC-zwf | 14.3 ± 1.3 | 6.1 ± 0.2* | 14.6 ± 0.5 |
| pEC-ppnk | 11.1 ± 0.6* | 6.2 ± 0.2* | 15.4 ± 0.4* |
| pEC-gnd | 14.6 ± 1.6 | 3.1 ± 0.2* | 14.4 ± 0.5 |
| pEC-pntAB | 22.9 ± 1.0* | 7.4 ± 0.4* | 17.6 ± 0.4* |
*Significantly different from the control strain.
Figure 4Batch culture of . ΔAPE6937R42 in 5 L bioreactor. (●) glucose; (■) OD600; (▲) L-ornithine.
Strains and plasmids used in this study
| Strain | | |
| supE44, hsdR17, recA1, thi-1, endA1, lacZ, gyrA96, relA1 | Invitrogen | |
| | | |
| ATCC 13032 | Wild-type | ATCC |
| ATCC 13032 ( | 15 | |
| This study | ||
| The evolved strain of ATCC 13032 ( | This study | |
| This study | ||
| This study | ||
| pK18mobsacB | 39 | |
| pK-JL | pK18mobsacB derivative, | This study |
| pMD18-T | TA cloning vector, Ampr | TaKaRa |
| pK-ΔargR | pK-JL with 506 bp deletion of the | This study |
| pEC-XK99E | 41 | |
| pEC-argBCG | pEC-XK99E containing the | This study |
| pEC-argBEC | pEC-XK99E containing the | This study |
| pEC-zwf | pEC-XK99E containing the | This study |
| pEC-ppnK | pEC-XK99E containing the | This study |
| pEC-gnd | pEC-XK99E containing the | This study |
| pEC-pntAB | pEC-XK99E containing the | This study |
Primers used in this study
| sacBF | cggcg | PCR for the |
| sacBR | gccgc | PCR for the |
| pk18msF | gcgcc | PCR for the backbone of pK18mobsacB except for the |
| pk18msR | gcgcg | PCR for the backbone of pK18mobsacB except for the |
| argR-F5 | cgct | PCR for the upstream fragment of the |
| argR-R5 | cgg | PCR for the upstream fragment of the |
| argR-F3 | cgg | PCR for the downstream fragment of the |
| argR-R3 | cgat | PCR for the downstream fragment of the |
| GargBF | cgc | PCR for the |
| GargBR | cgg | PCR for the |
| EargBF | cgt | PCR for the |
| EargBR | gcg | PCR for the |
| zwf-F | ccgcc | PCR for the |
| zwf-R | cggta | PCR for the |
| ppnK-F | gccat | PCR for the |
| ppnK-R | ccgcc | PCR for the |
| gnd-F | gcgat | PCR for the |
| gnd-R | ccgcg | PCR for the |
| pntAB-F | cag | PCR for the |
| pntAB-R | cgt | PCR for the |
| qpgiF | cccttctattctcggtgc | qRT-PCR for |
| qpgiR | aggtcatttgcctgctgt | qRT-PCR for |
| qpfkAF | tatccctgttgtcggtgtc | qRT-PCR for |
| qpfkAR | gtgagattcagcggtggt | qRT-PCR for |
| qgapF | ggaagttgaatacgacgatga | qRT-PCR for |
| qgapR | gcccagtccaggttcttt | qRT-PCR for |
| qpycF | accgccacgaaatccc | qRT-PCR for |
| qpycR | aacggctgcgtagttgtct | qRT-PCR for |
| qpykF | ccgtgcagtcggtattct | qRT-PCR for |
| qpykR | gcgttccctctacatcgt | qRT-PCR for |
| qgltAF | cgggaatcctgcgttac | qRT-PCR for |
| qgltAR | tggcgaatctcgtcgtt | qRT-PCR for |
| qgdhF | ccgccacatcggtgagta | qRT-PCR for |
| qgdhR | agccatgcgacggtagt | qRT-PCR for |
| qargBF | ggtttggtcggagacatca | qRT-PCR for |
| qargBR | gcctggagcaatcgtagag | qRT-PCR for |
| qargJF | cctgacatggcgttgg | qRT-PCR for |
| qargJR | ctcggctcaccttcaca | qRT-PCR for |
| qzwfF | acccgcaggataaacga | qRT-PCR for |
| qzwfR | gctagatcataaatggc | qRT-PCR for |
| qppnkF | gtttaccgaccgacttgtg | qRT-PCR for |
| qppnkR | gctgacctgggatctttatt | qRT-PCR for |
| qicdF | aggaccagggctacgacat | qRT-PCR for |
| qicdR | gcggaacccttaacagc | qRT-PCR for |
| qgndF | aaccgcagcactgacaaa | qRT-PCR for |
| qgndR | cagggatgctacgaactct | qRT-PCR for |
| 16s-F | tcgatgcaacgcgaagaac | qRT-PCR for |
| 16s-R | gaaccgaccacaagggaaaac | qRT-PCR for |
*Restriction enzyme sites are underlined.